As a cardiologist I have an older patient population. These individuals are at risk for COVID- 19. Unfortunately it is with a heavy heart that I have lost some patients. I am urging patients to keep their immune system strong with food, exercise and supplements
Patients with cardiovascular disease diagnosed with novel coronavirus (COVID-19) are urged to continue taking their (ACEi) and angiotensin receptor angiotensin and angiotension receptor blocking medications (ARB) as prescribed, according to a statement jointly published by the American Heart Association (AHA), the Heart Failure Society of America (HFSA), and the American College of Cardiology (ACC)
There were reports of benefits using these medications for COVID 19 Cardiovascular disease patients who are diagnosed with COVID-19 should be fully evaluated before adding or removing any treatments, and any changes to their treatment should be based on the latest scientific evidence and shared-decision making with their physician and healthcare team,” the press announcement stated. According to the joint statement, there have been no experimental or clinical data to support claims related to benefit or harm related to ACEi or ARB use in COVID-19 patients. The associations urged that modifications to ACEi or ARB treatment should only be made after a full evaluation of the individual patient is completed by a physician.
Please consult your health care practitioner before starting or stopping any medication during this pandemic